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bone. This supposition is supported by these data as concentrations of
uCTXII were highly correlated to the severity of OA as measured by osteo-
phyte formation, particularly of the medial compartment. The signiﬁcant
association of concentrations of collagenous urinary markers, ALPHA CTX
and CTXII, to knee bone turnover by bone scintigraphy suggests that these
markers may be useful non-invasive surrogates for active bone turnover in
knee osteoarthritis.
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Purpose: Osteoarthritis (OA) is the most common rheumatic pathology,
characterized mainly by cartilage degradation. Despite its high preva-
lence, the diagnosis methods currently available are limited and lacked
of sensitivity. Therefore, there is a considerable interest pointed in the
characterization of new speciﬁc OA biomarkers in biological ﬂuids. In
this work we aimed to set up a proteomic method for the large-scale
identiﬁcation and quantisation of proteins in serum from OA patients and
their comparison with healthy donors.
Methods: Serum samples were obtained from OA patients at different
stages of the disease (50 samples from grade II and 50 from grade IV),
and 50 control donors. To reduce interindividual variability, samples were
grouped in pools made from 10 patients. To reduce the dynamic range of
protein concentrations and be able to identify minority proteins, the top
twenty most abundant proteins in crude serum ﬂuids were removed by
aﬃnity chromatography using the immunodepletion column ProteoPrep®
20 (Sigma Aldrich). Proteins from each pool were quantiﬁed, digested with
trypsin and differentially labelled with isobaric tags using iTRAQ method-
ology (ABSCIEX). Then, peptides from the three conditions were mixed,
separated and analyzed by two dimensional LC coupled to MALDI-TOF/TOF
mass spectrometry. Identiﬁcation and relative quantiﬁcation of the proteins
were performed using ProteinPilot 2.0 software (ABSCIEX). Only proteins
identiﬁed with at least 95% conﬁdence were reported. PSPEP program was
used independently to calculate False Discovery Rates.
Results: The immunodepletion and subsequent proteomic analysis of the
samples led to the identiﬁcation of around 160 different proteins in the
serum pools, with at least one peptide and a conﬁdence higher than 99.9%.
Measurement of the different iTRAQ tags intensities allowed the relative
quantiﬁcation of each protein under the three conditions of the study
(control, OA grade II and OA grade IV). At this point, we have already
analyzed results from 60 samples. Data were normalized and we considered
signiﬁcant those changes with a ratio OA:N >1.2 or <0.8 and a p-value
below 0.05.
With these considerations, 29 proteins were found to be modiﬁed in the
serum of OA patients (17 increased and 12 decreased) when compared to
Table 1. Serum Proteins altered in OA patients when compared to healthy donors
Early OA (Grade II) Late OA (Grade IV) OA (Both stages)
Increased
Apolipoprotein E Complement C4-B Alpha-1B-glycoprotein
Beta-2-microglobulin Heparin cofactor 2 Alpha-2-HS-glycoprotein
Plasma protease C1 Histidine-rich glycoprotein Apolipoprotein B-100
inhibitor Thyroxine-binding globulin CD5 antigen-like
Vitamin K-dependent prot. S Complement C3
Ig lambda chain C





Apolipoprotein A-IV Alpha-2-macroglobulin Apolipoprotein A-I
Complement component Complement component C7 Attractin
C8 beta chain Plasma kallikrein Fibronectin
Glutathione peroxidase Plasma protease C1 inhibitor
Serum albumin
Zinc-alpha-2-glycoprotein
healthy donors (see Table 1). From these, 12 were altered independently
of the degree of the disease, 6 were modiﬁed only in early stages (grade
II), and 11 exclusively in advanced OA (grade IV). The reported altered
proteins, which are now putative OA biomarker candidates, are involved in
a wide range of biological functions, such as immune response, inﬂamma-
tion processes, lipid metabolism, oxidative stress defence, transport or cell
adhesion.
Conclusions: A number of novel putative OA serum protein biomarkers
have been described. Validation of these results on a higher number of
samples will be necessary for the design of a ﬁnal panel, which will
undoubtedly be useful for OA diagnosis and progression studies.
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Purpose: In kOA disease progression and chronic inﬂammation is pro-
moted by combinations of principle components of angiogenesis, the
kallikrein-kinin and rennin-angiotensin systems, which play essential roles
in the maintenance of vascular immune homeostasis.The humoral immune
response represents a form of biological ampliﬁcation of signals that are
otherwise weak due to very low concentrations of self-antigen, especially
in the early stages of kOA. To investigate the speciﬁc presence of NA
(IgM, IgG, IgA) to EM (BK, ANII, VEGF, bFGF) in the peripheral blood sera
of patients with kOA and healthy individuals: focusing on novel immune
disease-associated biomarkers of angiogenesis.
Methods: In order to quantify NA to EM in the sera, were designed,
synthesized and then used to develop an ELISA, in which antigens coupled
to matrix was coated on microtiters plates. Serum samples were incubated
in the plates, after which bound Ig anti-EM was detected with mouse
anti-human Ig-HRP. Levels NA-EM in a cohort of controls differed by more
than 100-fold, whereas the ﬂuctuation of EM-NA levels in individuals over
time was small (coeﬃcient of variation 8%). Following this procedure, we
examined variations in the levels of NA recognized a panel of self-antigens
in the sera from healthy individuals and kOA patients. Blood samples were
obtained from a cohort of 250 patients with symptomatic kOA (age range
45-79) fulﬁlling the American College of Rheumatology criteria for OA of
the knee joint and 250 age- and sex- matched healthy individuals. All
kOA patients had involvement of the knee joint with typical radiographic
changes graded Kellgren&Lawrence classiﬁcation. Pain was scored on a
visual analogue scale (VAS) immediately after walking 50 m. All kOA
patients are with persistent pain longer than 6 months. Parameters for
function were performed by Lequesne’s functional indexes.
Results: Different classes of NA (IgM, IgG, IgA) to EM (BK, ANII, VEGF, bFGF)
were detected with our ELISA protocol in the sera of kOA patients as well
as in the sera of healthy individuals. At time of inclusion kOA patients
(100%) had signiﬁcantly higher serum BK-IgG levels relative to normal
